Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-09

Clinical Trial Update: A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face [Phase 2]

View source ↗

Summary

Phase 2 trial update for azelaic acid 15% gel in treating seborrheic dermatitis on the face.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic acid 15% gel (azelaic acid)

Snippet

Sponsor: LEO Pharma | Conditions: Seborrheic Dermatitis on the Face | Phase 2 | Status: COMPLETED